graphic version rss
innovate, educate, improve lives
Home | Calendar | About Us | Our Offices |
Search: [Go]
Lawn & Garden
Family & Home
Money & Business
Food & Health
Environment &
Natural Resources
Kids & Teens

 more...>Intellectual Property>Success and Statistics>

Esperance Pharmaceuticals

Esperance Pharmaceuticals Inc. is a new Louisiana-based biopharmaceutical company that develops novel anticancer agents. Esperance uses patented technologies from the LSU AgCenter, Pennington Biomedical Research Center and Louisiana State University as a foundation for their revolutionary cancer treatments. Their newest drug, EP-100, is currently in Phase 2 clinical trials.

April 24, 2008
First Louisiana Biotech Company Focused on Cancer Announces Opening

October 5, 2009
New drug aims to 'seek and destroy' many types of cancer 

May 17, 2012
Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane‐disrupting Agent, EP‐ 100, in Patients with Advanced Ovarian Cancer

June 1, 2015
Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting

August 24, 2015
Esperance Announces Strategic Alliance with MD Anderson Cancer Center

For more information on Esperance Pharmaceuticals visit:
Last Updated: 11/3/2015 8:07:33 AM

Have a question or comment about the information on this page?
Click here to contact us.